BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 22.21 (2021): 11951.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2021
- Urheber
-
Hoyer, Stefanie
Eberlein, Valentina
Schuler, Gerold
Berking, Carola
Heinzerling, Lucie
Schaft, Niels
Dörrie, Jan
- DOI
-
10.3390/ijms222111951
- URN
-
urn:nbn:de:bvb:29-opus4-206793
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hoyer, Stefanie
- Eberlein, Valentina
- Schuler, Gerold
- Berking, Carola
- Heinzerling, Lucie
- Schaft, Niels
- Dörrie, Jan
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2021
Ähnliche Objekte (12)
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
Apoptoseinduktion durch BRAF, MEK Inhibition in humanen Melanomzellen
Efficacy of the MEK inhibitor trametinib in combination with disulfiram in BRAF-wild type melanoma cells
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
Influence of serotonin signaling on maturation, cytokine production, and T-cell priming of dendritic cells [Abstract]
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
Apoptoseinduktion durch BRAF, MEK Inhibition in humanen Melanomzellen
Efficacy of the MEK inhibitor trametinib in combination with disulfiram in BRAF-wild type melanoma cells
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
Influence of serotonin signaling on maturation, cytokine production, and T-cell priming of dendritic cells [Abstract]
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)
Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
Apoptoseinduktion durch BRAF, MEK Inhibition in humanen Melanomzellen
Efficacy of the MEK inhibitor trametinib in combination with disulfiram in BRAF-wild type melanoma cells
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma